Against all odds, researchers developed an RNA drug to “silence” a defective gene copy, offering a path to improved quality of life for a child with a rare developmental disorder.|  Read More  JPost.com – The Jerusalem Post – All News from the Middle East, Israel, and the Jewish World  | Read More in Virtual Jerusalem